Department of Internal Medicine, University of Cincinnati College of Medicine, Ohio, USA.
Ann Allergy Asthma Immunol. 2012 Sep;109(3):173-8. doi: 10.1016/j.anai.2012.06.013. Epub 2012 Jul 12.
Patients with chronic allergic rhinitis (AR) and nonallergic rhinitis (NAR) often experience irritant-induced symptoms. The clinical relevance of the magnitude of their symptoms in response to these nonspecific stimuli remains unclear.
To determine the internal consistency and validity of an irritant index questionnaire (IIQ) and whether reclassification of physician-diagnosed rhinitis subtypes based on IIQ scores results in rhinitis subtypes with different clinical characteristics.
Patients 18 to 65 years old with physician-diagnosed AR (n = 404), mixed rhinitis (MR; n = 129), or NAR (n = 123) completed an IIQ that rated rhinitis symptom severity in response to 21 nonallergic irritant triggers on a 1- to 10-point scale. Multistage sex-specific statistical analyses were performed using IIQ responses to reclassify physician-diagnosed AR, MR, and NAR into categories with high and low irritant burdens.
The IIQ demonstrated good internal consistency and cross-validation. After reclassification, 48% and 52% of patients with physician-diagnosed AR patients (n = 533) were categorized as having low-burden AR and high-burden AR, respectively, whereas 64% and 36% of NAR (n = 123) patients were categorized as having low-burden NAR and high-burden NAR, respectively. Reclassified high-burden AR and high-burden NAR patients were more likely to have a physician diagnosis of asthma and a greater number of self-reported rhinitis symptoms and perennial symptoms with seasonal exacerbations than reclassified low-burden AR and low-burden NAR patients, respectively (P < .01).
The IIQ resulted in significant reclassification of physician-diagnosed rhinitis patients into different diagnostic categories with unique clinical characteristics. Further studies are necessary to confirm the IIQ's utility as a tool for characterizing rhinitis patients in clinical practice and research.
慢性过敏性鼻炎(AR)和非过敏性鼻炎(NAR)患者常出现刺激性诱导症状。这些非特异性刺激物引起的症状严重程度对他们的临床意义尚不清楚。
确定刺激性指数问卷(IIQ)的内部一致性和有效性,以及根据 IIQ 评分重新分类医生诊断的鼻炎亚型是否会导致具有不同临床特征的鼻炎亚型。
18 至 65 岁的、经医生诊断为 AR(n = 404)、混合性鼻炎(MR;n = 129)或 NAR(n = 123)的患者完成了 IIQ,该问卷按 1 至 10 分制对 21 种非过敏性刺激性触发物引起的鼻炎症状严重程度进行评分。使用 IIQ 反应对经医生诊断的 AR、MR 和 NAR 进行多阶段性别特异性统计分析,将其重新分类为高和低刺激性负担类别。
IIQ 显示出良好的内部一致性和交叉验证。重新分类后,48%和 52%的经医生诊断为 AR 患者(n = 533)分别被归类为低负担 AR 和高负担 AR,而 64%和 36%的 NAR 患者(n = 123)分别被归类为低负担 NAR 和高负担 NAR。与重新分类的低负担 AR 和低负担 NAR 患者相比,重新分类的高负担 AR 和高负担 NAR 患者更有可能被诊断为哮喘,并且有更多的自述鼻炎症状和季节性加重的常年症状(P <.01)。
IIQ 可显著将经医生诊断的鼻炎患者重新分类为具有独特临床特征的不同诊断类别。需要进一步的研究来证实 IIQ 作为一种在临床实践和研究中描述鼻炎患者的工具的实用性。